stockgist
HomeTop MoversCompaniesConcepts

Market

  • Top Movers
  • Companies
  • Concepts

SEC Filings

  • AI Filing Analysis
  • Financial Reports
  • Current Reports
  • IPO Filings

Ownership

  • Institutional Holdings
  • Insider Trading

About

  • Data updates every 5 min
  • SEC EDGAR Source
© 2025–2026 StockGist|Information only, not investment advice
    1. Companies
    2. NVOS
    stockgist
    HomeTop MoversCompaniesConcepts
    NVOS logo

    Novo Integrated Sciences, Inc.

    NVOS
    OTC
    Healthcare
    Medical - Care Facilities
    Bellevue, WA, US115 employeesnovointegrated.com
    —

    At A Glance

    1

    Novo Integrated Sciences, Inc., together with its subsidiaries, provides multidisciplinary primary health care related products and services.

    2

    Revenue is primarily driven by Health Care Services (63.9%) and Product Sales (35.8%).

    3

    No significant events in the past 90 days.

    —

    Market Cap

    —

    Revenue

    —

    Net Income

    Employees115
    Fundamentals

    How The Business Makes Money

    Revenue by Segment

    Health Care Services63.9%($17M)
    Product Sales35.8%($9M)
    Corporate0.3%($88.0K)
    Activity

    What Changed Recently

    No significant events in the past 90 days.

    Peer Companies

    CompanyPriceChangeMarket CapP/E
    OMHEOmni Health, Inc.————
    ACGIACGI————
    SONXSonendo, Inc.————
    BBBTBlack Bird Biotech, Inc.————
    BRAXFBraxia Scientific Corp.————
    ADVTAdvantis Corp.————
    PBLAPanbela Therapeutics, Inc...————
    JNHMFJack Nathan Medical Corp.————
    Analyst View
    Company Profile
    CIK0001138978
    ISINUS67011T3005
    CUSIP67011T201
    Phone206 617 9797
    Address11120 NE 2nd Street, Bellevue, WA, 98004, US
    SEC EDGAR

    Market

    • Top Movers
    • Companies
    • Concepts

    SEC Filings

    • AI Filing Analysis
    • Financial Reports
    • Current Reports
    • IPO Filings

    Ownership

    • Institutional Holdings
    • Insider Trading

    About

    • Data updates every 5 min
    • SEC EDGAR Source
    © 2025–2026 StockGist|Information only, not investment advice